Switch to:
GlaxoSmithKline PLC (NYSE:GSK)
Additional Paid-In Capital
$4,058 Mil (As of Jun. 2016)

GlaxoSmithKline PLC's quarterly additional paid-in capital declined from Dec. 2015 ($4,238 Mil) to Mar. 2016 ($4,046 Mil) but then increased from Mar. 2016 ($4,046 Mil) to Jun. 2016 ($4,058 Mil).

GlaxoSmithKline PLC's annual additional paid-in capital increased from Dec. 2012 ($3,267 Mil) to Dec. 2013 ($4,247 Mil) and increased from Dec. 2013 ($4,247 Mil) to Dec. 2014 ($4,318 Mil).


Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)*Shares Outstanding

Related Terms

Shares Outstanding

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

GlaxoSmithKline PLC Annual Data

AdditionalPaidInCapital 1,6852,5551,9702,2212,2282,6103,2674,2474,3184,238

GlaxoSmithKline PLC Quarterly Data

AdditionalPaidInCapital 4,4444,5794,4254,3184,1664,3494,2874,2384,0464,058
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)